Cardiac program revived

By Julie M. McKinnon, Toledo Blade

The owner of Loma Linda and other local restaurants is so grateful for the life-saving heart transplant he received 11 years ago, that he and his wife are giving $1 million to help revive the program in Toledo.

Continue reading

Columbus Cardiothoracic Surgeon Launches New Site on State-of-the-Art Atrial Fibrillation Treatment


Dr. John H. Sirak, a heart surgeon at Ohio State University, has launched a new Web site ( to educate people living with atrial fibrillation (AF) and their family members about the condition and explain the full range of treatment options, including medical management, catheter ablation, and surgical approaches such as totally thoracoscopic maze surgery. For several years, Dr. Sirak has been innovating surgical treatment techniques that offer the ability to cure atrial fibrillation and return the heart to a normal rhythm and rate.

Continue reading

Shoulder Injuries In US High School Athletes Occur More Often In Boys


Although shoulder injuries accounted for just 8 percent of all injuries sustained by high school athletes, shoulder injuries were relatively common in predominately male sports such as baseball (18 percent of all injuries), wrestling (18 percent) and football (12 percent). Moreover, boys experienced higher shoulder injury rates than girls, particularly in soccer and baseball/softball.

Continue reading

West Penn names new cardiac surgery chief

Pittsburgh Post-Gazette

Dr. Walter E. McGregor, formerly of Riverside Methodist Hospital in Columbus, Ohio, has been named chief of the Division of Cardiac Surgery at West Penn Hospital. He is expected to join the West Penn Allegheny Health System on March 1.

Continue reading

Engineered virus targets and kills apparent cancer stem cells in neuroblastoma

Published online Jan. 21 by PLoS (Public Library of Science) One, the study led by Cincinnati Children’s Hospital Medical Center adds to a growing body of evidence suggesting early stage cancer precursor cells with stem-cell-like properties may explain how some cancers form, are treatment resistant and prone to relapse. The study also underscores the increasing potential of targeted biological therapies to help people with stubborn cancers like neuroblastoma, which often recur and metastasize, said Timothy Cripe, M.D., Ph.D., senior investigator and a physician/researcher in the division of Hematology/Oncology at Cincinnati Children’s.

Continue reading